128 related articles for article (PubMed ID: 19437318)
1. Plasma heparanase as a significant marker of treatment response in children with Hodgkin lymphoma: pilot study.
Ben Arush MW; Shafat I; Ben Barak A; Shalom RB; Vlodavsky I; Ilan N
Pediatr Hematol Oncol; 2009 Jun; 26(4):157-64. PubMed ID: 19437318
[TBL] [Abstract][Full Text] [Related]
2. Serum VEGF as a significant marker of treatment response in hodgkin lymphoma.
Ben Arush MW; Ben Barak A; Maurice S; Livne E
Pediatr Hematol Oncol; 2007 Mar; 24(2):111-5. PubMed ID: 17454776
[TBL] [Abstract][Full Text] [Related]
3. [Vascular endothelial growth factor and interleukin 6 production by Hodgkin lymphoma].
Kobayashi K; Yokote T; Akioka T; Hara S; Oka S; Hiraoka N; Hirata Y; Miyoshi T; Tsuji M; Hanafusa T
Gan To Kagaku Ryoho; 2007 Aug; 34(8):1327-30. PubMed ID: 17687225
[TBL] [Abstract][Full Text] [Related]
4. Serum soluble interleukin-2 receptor, beta2-microglobulin, lactate dehydrogenase and erythrocyte sedimentation rate in children with Hodgkin's lymphoma.
Bien E; Balcerska A
Scand J Immunol; 2009 Nov; 70(5):490-500. PubMed ID: 19874554
[TBL] [Abstract][Full Text] [Related]
5. Resection alone in 58 children with limited stage, lymphocyte-predominant Hodgkin lymphoma-experience from the European network group on pediatric Hodgkin lymphoma.
Mauz-Körholz C; Gorde-Grosjean S; Hasenclever D; Shankar A; Dörffel W; Wallace WH; Schellong G; Robert A; Körholz D; Oberlin O; Hall GW; Landman-Parker J
Cancer; 2007 Jul; 110(1):179-85. PubMed ID: 17526010
[TBL] [Abstract][Full Text] [Related]
6. Serum vascular endothelial growth factor as a significant marker of treatment response in pediatric malignancies.
Ben Arush MW; Schenzer P; Maurice S; Elhasid R; Postovsky S; Ben Barak A; Haimi M; Zeidman I; Hayari L; Livne E
Pediatr Hematol Oncol; 2005 Sep; 22(6):513-24. PubMed ID: 16169818
[TBL] [Abstract][Full Text] [Related]
7. Prognostic value of proangiogenic cytokines in children with lymphomas.
Mizia-Malarz A; Sobol G; Janowska J; Wos H; Zahorska-Markiewicz B
Pediatr Blood Cancer; 2009 Dec; 53(7):1195-9. PubMed ID: 19621434
[TBL] [Abstract][Full Text] [Related]
8. Serum level of intercellular adhesion molecule-1 in children with malignant lymphoma.
Abdelrazik N; Fouda M; Zaghloul MH; Abbas D
Med Princ Pract; 2008; 17(3):233-8. PubMed ID: 18408393
[TBL] [Abstract][Full Text] [Related]
9. Escalated-dose BEACOPP in the treatment of patients with advanced-stage Hodgkin's lymphoma: 10 years of follow-up of the GHSG HD9 study.
Engert A; Diehl V; Franklin J; Lohri A; Dörken B; Ludwig WD; Koch P; Hänel M; Pfreundschuh M; Wilhelm M; Trümper L; Aulitzky WE; Bentz M; Rummel M; Sezer O; Müller-Hermelink HK; Hasenclever D; Löffler M
J Clin Oncol; 2009 Sep; 27(27):4548-54. PubMed ID: 19704068
[TBL] [Abstract][Full Text] [Related]
10. C-reactive protein (CRP) as tumor marker in pediatric and adolescent patients with Hodgkin disease.
Wieland A; Kerbl R; Berghold A; Schwinger W; Mann G; Urban C
Med Pediatr Oncol; 2003 Jul; 41(1):21-5. PubMed ID: 12764738
[TBL] [Abstract][Full Text] [Related]
11. Elevated serum levels of CC thymus and activation-related chemokine (TARC) in primary Hodgkin's disease: potential for a prognostic factor.
Weihrauch MR; Manzke O; Beyer M; Haverkamp H; Diehl V; Bohlen H; Wolf J; Schultze JL
Cancer Res; 2005 Jul; 65(13):5516-9. PubMed ID: 15994922
[TBL] [Abstract][Full Text] [Related]
12. Developing anticancer chemotherapy services in a developing country: Hodgkin lymphoma experience.
Chandra J; Naithani R; Singh V; Saxena YK; Sharma M; Pemde H
Pediatr Blood Cancer; 2008 Oct; 51(4):485-8. PubMed ID: 18636462
[TBL] [Abstract][Full Text] [Related]
13. [Results of the monitoring the group of patients treated for the Hodgkin disease in the period of 1971 to 1996. Part 1: long-time survival in dependence of the clinical stage of the disease].
Fridrichova M; Dienstbier Z; Loucka M; Skala E; Blomannová E
Klin Onkol; 2008; 21(3):110-5. PubMed ID: 19097420
[TBL] [Abstract][Full Text] [Related]
14. [Lymphomas in adolescents: are childhood lymphoma therapy protocols suitable for this patient group?].
Bence Z; Kovács G; Jakab Z; Csóka M; Müller J
Magy Onkol; 2008 Dec; 52(4):357-62. PubMed ID: 19068463
[TBL] [Abstract][Full Text] [Related]
15. ABVD compared with BEACOPP compared with CEC for the initial treatment of patients with advanced Hodgkin's lymphoma: results from the HD2000 Gruppo Italiano per lo Studio dei Linfomi Trial.
Federico M; Luminari S; Iannitto E; Polimeno G; Marcheselli L; Montanini A; La Sala A; Merli F; Stelitano C; Pozzi S; Scalone R; Di Renzo N; Musto P; Baldini L; Cervetti G; Angrilli F; Mazza P; Brugiatelli M; Gobbi PG;
J Clin Oncol; 2009 Feb; 27(5):805-11. PubMed ID: 19124807
[TBL] [Abstract][Full Text] [Related]
16. The treatment of childhood Hodgkin lymphoma: improved survival in a developing country.
Büyükpamukçu M; Varan A; Akyüz C; Atahan L; Ozyar E; Kale G; Köksal Y; Kutluk T
Acta Oncol; 2009; 48(1):44-51. PubMed ID: 18777215
[TBL] [Abstract][Full Text] [Related]
17. Heparanase levels are elevated in the plasma of pediatric cancer patients and correlate with response to anticancer treatment.
Shafat I; Barak AB; Postovsky S; Elhasid R; Ilan N; Vlodavsky I; Arush MW
Neoplasia; 2007 Nov; 9(11):909-16. PubMed ID: 18030359
[TBL] [Abstract][Full Text] [Related]
18. High serum levels of B-lymphocyte stimulator are associated with clinical-pathological features and outcome in classical Hodgkin lymphoma.
Tecchio C; Nadali G; Scapini P; Bonetto C; Visco C; Tamassia N; Vassilakopoulos TP; Pangalis GA; Calzetti F; Nardelli B; Roschke V; Gottardi M; Zampieri F; Gherlinzoni F; Facchetti F; Pizzolo G; Cassatella MA
Br J Haematol; 2007 Jun; 137(6):553-9. PubMed ID: 17539776
[TBL] [Abstract][Full Text] [Related]
19. Non-Hodgkin lymphoma (NHL) in children with Nijmegen Breakage syndrome (NBS).
Dembowska-Baginska B; Perek D; Brozyna A; Wakulinska A; Olczak-Kowalczyk D; Gladkowska-Dura M; Grajkowska W; Chrzanowska KH
Pediatr Blood Cancer; 2009 Feb; 52(2):186-90. PubMed ID: 18937313
[TBL] [Abstract][Full Text] [Related]
20. Hodgkin lymphoma in Tyrol-a population-based study.
Fong D; Steurer M; Greil R; Gunsilius E; Spizzo G; Gastl G; Tzankov A
Ann Hematol; 2009 May; 88(5):449-56. PubMed ID: 18846373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
